Immunotherapy in the Treatment of Metastatic Melanoma: Current Knowledge and Future Directions.

Journal of Immunology Research
Massimo RalliAntonio Greco

Abstract

Melanoma is one of the most immunologic malignancies based on its higher prevalence in immune-compromised patients, the evidence of brisk lymphocytic infiltrates in both primary tumors and metastases, the documented recognition of melanoma antigens by tumor-infiltrating T lymphocytes and, most important, evidence that melanoma responds to immunotherapy. The use of immunotherapy in the treatment of metastatic melanoma is a relatively late discovery for this malignancy. Recent studies have shown a significantly higher success rate with combination of immunotherapy and chemotherapy, radiotherapy, or targeted molecular therapy. Immunotherapy is associated to a panel of dysimmune toxicities called immune-related adverse events that can affect one or more organs and may limit its use. Future directions in the treatment of metastatic melanoma include immunotherapy with anti-PD1 antibodies or targeted therapy with BRAF and MEK inhibitors.

References

Jan 1, 1995·The Journal of Clinical Endocrinology and Metabolism·T YanagawaL J DeGroot
Nov 18, 2005·The New England Journal of Medicine·John A CurtinBoris C Bastian
Mar 21, 2008·Nature Reviews. Cancer·Steven A RosenbergMark E Dudley
Jun 21, 2008·The New England Journal of Medicine·Naomi N HunderCassian Yee
Nov 26, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jedd D WolchokF Stephen Hodi
Mar 13, 2010·Journal of Oncology·Niels HalamaDirk Jaeger
Sep 9, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Evan J Lipson, Charles G Drake
Oct 1, 2011·Progress in Biophysics and Molecular Biology·Sara GandiniMathieu Boniol
Dec 24, 2011·Nature·Ira MellmanGlenn Dranoff
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Jun 5, 2012·The New England Journal of Medicine·Julie R BrahmerJon M Wigginton
Jun 8, 2012·Science Translational Medicine·Steven K SeungWalter J Urba
Aug 29, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M Maio
Jul 31, 2013·Immunity·Daniel S Chen, Ira Mellman
Dec 21, 2013·Science·Jennifer Couzin-Frankel
May 30, 2014·Science Translational Medicine·Edward ChaLawrence Fong
Sep 13, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R SalgadoUNKNOWN International TILs Working Group 2014
Nov 20, 2014·The New England Journal of Medicine·Alexandra SnyderTimothy A Chan
Aug 1, 2013·Clinical & Translational Immunology·David E GyorkiCharlotte E Ariyan
Dec 19, 2014·Acta Dermato-venereologica·Emanual MaverakisForum Patel
Dec 30, 2014·Oncotarget·Lorenzo GalluzziGuido Kroemer
Jan 22, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hansje-Eva TeulingsRosalie M Luiten
Jan 22, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael A PostowJedd D Wolchok
Feb 11, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dirk SchadendorfJedd D Wolchok
Mar 10, 2015·Clinical Therapeutics·Elizabeth I Buchbinder, David F McDermott
Apr 1, 2015·Clinical Therapeutics·Kathleen M MahoneyDavid F McDermott
Apr 11, 2015·Cancer Cell·Jacques F A P Miller, Michel Sadelain
Apr 11, 2015·Cancer Cell·Suzanne L TopalianDrew M Pardoll
Apr 22, 2015·The New England Journal of Medicine·Caroline RobertUNKNOWN KEYNOTE-006 investigators
May 13, 2015·Seminars in Oncology·Imran RafiqueAhmad A Tarhini
Jun 19, 2015·Acta Dermato-venereologica·Shedia M HammoudVigfús Sigurdsson
Jul 28, 2015·The Journal of Clinical Investigation·Cornelis J M MeliefSjoerd H van der Burg
Sep 1, 2013·EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [et Al.]·John B A G Haanen
Aug 5, 2015·The Journal of Clinical Investigation·Michele W L TengMark J Smyth
Aug 12, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Victoria L Chiou, Mauricio Burotto
Sep 1, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R DummerUNKNOWN ESMO Guidelines Committee
Sep 12, 2015·Science·Eliezer M Van AllenLevi A Garraway
Sep 24, 2015·The New England Journal of Medicine·Matias E Valsecchi
Nov 13, 2015·American Journal of Clinical Oncology·Elizabeth I Buchbinder, Anupam Desai
Nov 26, 2015·Cancer Treatment and Research·Batool ShannanMeenhard Herlyn
Nov 26, 2015·Cancer Treatment and Research·Melissa A Wilson, Lynn M Schuchter

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies

Software Mentioned

SECOMBIT

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.